Uncategorized
VIDEO: Eyenovia’s microdosing technology promising for treating progressive myopia
CHICAGO — At the Ophthalmology Innovation Summit at the American Academy of Ophthalmology meeting, Sean Ianchulev, MD, MPH, president and CEO of Eyenovia,discusses the company’s microdosing technology for the treatment of progressive myopia.